We are live on ! Find out more
NRX

NEPHROGENEX INC COM
NRX

Delisted

NRX was delisted on the 10th of May, 2016.

Back to rankings

13 hedge funds and large institutions have $8.87M invested in NEPHROGENEX INC COM in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 1

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less funds holding

Funds holding: 14 → 13 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

40% less capital invested

Capital invested by funds: $14.7M → $8.87M (-$5.83M)

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.36%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
8
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TI
Turner Investments
Pennsylvania
+$1.08M
2
VAM
Visium Asset Management
New York
+$570K
3
JP Morgan Chase
JP Morgan Chase
New York
+$138K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$120K
5
Morgan Stanley
Morgan Stanley
New York
+$112K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$498K
2
UBS Group
UBS Group
Switzerland
-$4K
3
TRCT
Tower Research Capital (TRC)
New York
-$1K
4
Citigroup
Citigroup
New York
-$92
Name Holding Trade Value Shares
Change 		Change in
Stake
RCP
1
Rho Capital Partners
New York
$3.56M – – –
VAM
2
Visium Asset Management
New York
$2.67M +$570K +130,000 +20%
TI
3
Turner Investments
Pennsylvania
$1.25M +$1.08M +245,030 +197%
Morgan Stanley
4
Morgan Stanley
New York
$693K +$112K +25,620 +14%
Vanguard Group
5
Vanguard Group
Pennsylvania
$342K +$56.6K +12,900 +15%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$138K +$120K +27,286 +200%
JP Morgan Chase
7
JP Morgan Chase
New York
$107K +$138K +31,536 New
BFA
8
BlackRock Fund Advisors
California
$56K +$32K +7,285 +78%
Bank of America
9
Bank of America
North Carolina
$38K +$8.78K +2,000 +22%
VIA
10
Vantage Investment Advisors
Pennsylvania
$13K +$16.2K +3,700 New
BIM
11
BlackRock Investment Management
Delaware
$3K +$623 +142 +21%
EWM
12
Edge Wealth Management
New York
$2K – – –
Millennium Management
13
Millennium Management
New York
– -$498K -75,000 Closed
UBS Group
14
UBS Group
Switzerland
– -$4K -591 Closed
TRCT
15
Tower Research Capital (TRC)
New York
– -$1K -200 Closed
Citigroup
16
Citigroup
New York
– -$92 -21 -17%

NRX Hedge Fund Activity: Q3 2015 in Review

13 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in NEPHROGENEX INC COM (NRX) for Q3 2015, worth a combined $8.87M — down 40% from $14.7M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of NRX and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 8 added.

The largest buyer was Turner Investments, adding an estimated $1.08M. The largest seller was Millennium Management, exiting entirely with an estimated $498K sold.

  • 13 institutional investors held NEPHROGENEX INC COM (NRX) as of Q3 2015, down from 14 in Q2 2015.
  • Funds reported $8.87M of NEPHROGENEX INC COM stock for Q3 2015, down 40% quarter-over-quarter.
  • 2 funds opened new NEPHROGENEX INC COM positions in Q3 2015 and 3 closed out, a net change of -1 holder.
  • The largest NEPHROGENEX INC COM buyer in Q3 2015 was Turner Investments, an estimated $1.08M added.
  • The largest NEPHROGENEX INC COM seller in Q3 2015 was Millennium Management, an estimated $498K sold.

Based on aggregated 13F filings for Q3 2015.